Inventor · disambiguated record
Giorgio Trinchieri
Also filed as: TRINCHIERI GIORGIO
20 granted patents·9 pending applications·1,055 citations·filing 1990–2022
97Inventor score
Files withUNIV PENNSYLVANIA6GENETICS INST5WISTAR INST5SCHERING CORP4UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION2
Top patents by PatentIndex Score
29 records- 0196US5723127ACompositions and methods for use of IL-12 as an adjuvantUNIV PENNSYLVANIA·Filed 1996·Granted Mar 3, 1998·178 cites·8 claims
- 0295US5457038ANatural killer stimulatory factorGENETICS INST·Filed 1990·Granted Oct 10, 1995·121 cites·12 claims
- 0394US5571515ACompositions and methods for use of IL-12 as an adjuvantWISTAR INST·Filed 1994·Granted Nov 5, 1996·108 cites·3 claims
- 0492US5872154AMethod of reducing an immune response to a recombinant adenovirusUNIV PENNSYLVANIA·Filed 1995·Granted Feb 16, 1999·146 cites·21 claims
- 0592US5811523AAntibodies to natural killer stimulatory factorFiled 1997·Granted Sep 22, 1998·79 cites·7 claims
- 0692US5648467ANatural killer cell stimulatory factorGENETICS INST·Filed 1995·Granted Jul 15, 1997·91 cites·10 claims
- 0788US6875580B2Antibodies specific for plasmacytoid dendritic cellsSCHERING CORP·Filed 2004·Granted Apr 5, 2005·22 cites·6 claims
- 0885US6300478B1Antibodies to natural killer stimulatory factorGENETICS INST·Filed 1999·Granted Oct 9, 2001·36 cites·2 claims
- 0982US6375944B1Methods and compositions for enhancing the immunostimulatory effect of interleukin-12WISTAR INST·Filed 1999·Granted Apr 23, 2002·55 cites·18 claims
- 1076US7122633B2Natural killer stimulatory factorWYETH CORP·Filed 2003·Granted Oct 17, 2006·2 cites·13 claims
- 1175US6168923B1Compositions and methods for use of IL-12 as an adjuvantWISTAR INST·Filed 1999·Granted Jan 2, 2001·30 cites·16 claims
- 1274US6251957B1Method of reducing an immune response to a recombinant virusUNIV PENNSYLVANIA·Filed 1996·Granted Jun 26, 2001·42 cites·45 claims
- 1374US2010086560A1Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2009·Application pending·0 cites
- 1473US6555658B2Antibodies to natural killer stimulatory factorWYETH CORP·Filed 2001·Granted Apr 29, 2003·1 cites·4 claims
- 1573US5648072AMethods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factorGENETICS INST·Filed 1995·Granted Jul 15, 1997·24 cites·8 claims
- 1669US5976539ACompositions and methods for use of IL-12 as an adjuvantWISTAR INST·Filed 1997·Granted Nov 2, 1999·19 cites·14 claims
- 1769US2007104680A1Antibodies to natural killer stimulatory factorWYETH AND THE WISTAR INST·Filed 2006·Application pending·0 cites
- 1868US2007166280A1Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2007·Application pending·0 cites
- 1967US6086876AMethods and compositions for the inhibition of interleukin-12 productionWISTAR INSITUTE·Filed 1998·Granted Jul 11, 2000·44 cites·12 claims
- 2066US5688690AHuman cytotoxic lymphocyte signal transduction surface protein (P38) and monoclonal antibodies theretoWISTAR INST·Filed 1994·Granted Nov 18, 1997·29 cites·3 claims
- 2160US2024277778A1Compositions and methods for determining responsiveness to immune checkpoint inhibitors (ici), increasing effectiveness of ici, and treating cancerUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 2259US6372208B1Method of reducing an immune response to a recombinant virusUNIV PENNSYLVANIA·Filed 1999·Granted Apr 16, 2002·17 cites·8 claims
- 2359US5569454AMethods of treating infection using natural killer stimulatory factorGENETICS INST·Filed 1995·Granted Oct 29, 1996·11 cites·4 claims
- 2459US2024041931A1Compositions and methods for treating cancerUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2021·Application pending·0 cites
- 2559US2003077247A1Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2002·Application pending·0 cites
- 2654US2003219435A9Method of reducing an immune response to a recombinant virusUNIV PENNSYLVANIA·Filed 2001·Application pending·0 cites
- 2752US2002081277A1Methods and compositions for enhancing the immunostimulatory effect of interleukin-12Filed 2002·Application pending·0 cites
- 2841US9475839B2Peptide-based inhibitor of interleukin-10 or interferon-gamma signalingTARASOVA NADYA I·Filed 2011·Granted Oct 25, 2016·0 cites·20 claims
- 2940US2003147871A1Method and compositions for inhibiting angiogenesis and treating cancer with IL-12 and IL-18UNIV PENNSYLVANIA·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →